Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid Nanoparticles For Enhancing Vinpocetine's Oral Bioavailability.

Yifan Luo, D. Chen, LiXiang Ren, X. Zhao, J. Qin
Published 2006 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
An ultrasonic-solvent emulsification technique was adopted to prepare vinpocetine loaded Glyceryl monostearate (GMS) nanodispersions with narrow size distribution. To increase the lipid load the process was conducted at 50 degrees C, and in order to prepare nanoparticle using an ultrasonic-solvent emulsification technique. The mean particle size and droplet size distribution, drug loading capacity, drug entrapment efficiency (EE%), zeta potential, and long-term physical stability of the SLNs were investigated in detail respectively. Drug release from two sorts of VIN-SLN was studied using a dialysis bag method. A pharmacokinetic study was conducted in male rats after oral administration of 10 mg kg(-1) VIN in different formulations, it was found that the relative bioavailability of VIN in SLNs was significantly increased compared with that of the VIN solution. The amount of surfactant also had a marked effect on the oral absorption of VIN with SLN formulations. The absorption mechanism of the SLN formulations was also discussed. These results indicated that VIN absorption is enhanced significantly by employing SLN formulations. SLNs offer a new approach to improve the oral bioavailability of poorly soluble drugs.
This paper references
10.1016/S0378-5173(02)00081-9
Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization.
F. Hu (2002)
10.1016/J.JCONREL.2005.05.016
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Keon-Hyoung Song (2005)
10.1016/S0378-5173(03)00365-X
Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion.
G. Nicolaos (2003)
Solid lipid nanoparticles (SLN) for controlled drug delivery: II
C. Schwarz (1999)
Pharmacokinetics of apovincaminic acid in dogs.
L. Vereczkey (1987)
10.1016/S0168-3659(99)00007-3
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.
S. Yang (1999)
Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release
A. zur Muhlen (1998)
10.1016/S0928-0987(01)00186-5
Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats.
R. Holm (2001)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
Pharmacokinetics and metabolism of vincamine and related compounds , Eur
S. Crauste-Manciet G. Nicolaos (1985)
Solid lipid nanoparticles : production , characterization and applications , Adv
K. Mader W. Mehnert (2001)
Solid lipid nanoparticles: production
W. Mehnert (2001)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
Mehnert , Solid lipid nanoparticles ( SLN ) for controlled drug deliverydrug release and release mechanism
C. Schwarz A. zur Muhlen (1998)
10.1079/BJN2003946
Enteral administration of soybean lecithin enhanced lymphatic absorption of triacylglycerol in rats.
M. Nishimukai (2003)
10.1016/S0378-5173(03)00087-5
Bioadhesive microspheres as a controlled drug delivery system.
Jaspreet K. Vasir (2003)
The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells.
Fergal Seeballuck (2003)
Commonly used surfactant
H. Zhang (2003)
10.1007/BF02976689
Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats
H. Zhang (2003)
10.1023/A:1024422625596
The Effects of Pluronic® Block Copolymers and Cremophor® EL on Intestinal Lipoprotein Processing and the Potential Link with P-Glycoprotein in Caco-2 Cells
Fergal Seeballuck (2004)
10.1016/S0939-6411(97)00097-0
Bioadhesion of solid oral dosage forms, why and how?
D. Duchěne (1997)
10.1080/026520499289185
Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.
C. Schwarz (1999)
Mehnert , Solid lipid nanoparticles ( SLN ) for controlled drug delivery : II . Drug incorporation and physicochemical characterization
W. C. Schwarz (1999)
10.1080/02652040010018056
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
A. Dingler (2002)
Arzneistoffträger aus festen Lipidteilchen
R. H. Müller (1996)
10.1016/J.JCONREL.2005.11.009
Gastro-intestinal patch system for the delivery of erythropoietin.
N. Venkatesan (2006)
10.1016/0378-5173(93)90177-H
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
10.2165/00003088-200140030-00002
The Gut as a Barrier to Drug Absorption
Y Zhang (2001)
In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
T. Szakâcs (2001)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)
10.1248/BPB.16.254
Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin.
D. Kobayashi (1993)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1016/S0928-0987(02)00051-9
Lipid-based formulations for intestinal lymphatic delivery.
C. O'Driscoll (2002)
10.1006/PHRS.1999.0509
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
G. Zara (1999)
Preparation of solid lipid nanoparticles containing volatile oil of Lignum dalbergia odoriferae
H. Jing (2004)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)



This paper is referenced by
10.1007/978-1-4471-4213-3_2
Synthesis of Organic and Bioorganic Nanoparticles: An Overview of the Preparation Methods
J. Allouche (2013)
10.3109/03639045.2010.516264
Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex
Kasongo Wa Kasongo (2011)
Solid lipid nanoparticles :A promising tool for drug delivery system
B. Basu (2010)
10.3109/03639040903485716
Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil
Xiu-Li Zhao (2010)
10.1080/10717544.2017.1388453
Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets
Mengqi Liu (2017)
10.1007/s11095-011-0415-8
Enhanced Oral Bioavailability of Vinpocetine Through Mechanochemical Salt Formation: Physico-Chemical Characterization and In Vivo Studies
D. Hasa (2011)
10.2147/IJN.S75615
Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures
K. Murugan (2015)
10.1016/j.xphs.2016.09.017
Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization.
S. Golob (2016)
FORMULATION AND EVALUATION OF VINPOCETINE LOADED LIPOSPHERES
Khulbe Preeti (2012)
10.1111/jphp.12136
Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository
R. A. Mohamed (2013)
10.1002/jps.22435
Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
M. K. Rawat (2011)
10.1080/10837450.2017.1335321
Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet
Sally A. El-Zahaby (2018)
10.1016/j.jconrel.2010.01.008
An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
S. Simović (2010)
10.1016/j.ejpb.2016.09.008
Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.
O. S. Qureshi (2016)
10.1002/9783527800681.CH24
Nanodrugs in Medicine and Healthcare: Oral Delivery
A. Sosnik (2016)
10.1016/j.colsurfb.2010.07.058
Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles.
S. Chakraborty (2010)
10.1124/PR.112.005660
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
10.1016/j.ejpb.2008.09.015
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.
A. Del Pozo-Rodríguez (2009)
10.3109/08982100903443065
Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability
J. Varshosaz (2010)
10.15171/apb.2018.027
Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis
S. Ojha (2018)
10.3109/10837450.2012.734513
Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization
N. Morsi (2013)
10.2147/IJN.S86053
pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells
H. Chen (2015)
10.1016/j.ijpharm.2009.01.014
Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.
Qingzhi Lv (2009)
10.3109/13880209.2014.991836
Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles
M. Eskandani (2015)
10.1208/s12249-015-0299-8
Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations
Y. Liu (2015)
10.1002/mnfr.201000310
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
10.3109/10717544.2014.918677
Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin
Hongyu Ji (2016)
Formulation, Optimization and In vitro Characterization of Letrozole Loaded Solid Lipid Nanoparticles
Archana Nerella (2014)
10.3109/10717544.2014.885999
Optimization of artemether-loaded NLC for intranasal delivery using central composite design
Kunal Jain (2015)
10.1007/s11745-012-3731-9
Uptake of α-Linolenic Acid and Its Conversion to Long Chain Omega-3 Fatty Acids in Rats Fed Microemulsions of Linseed Oil
D. Sugasini (2012)
10.1007/S11051-009-9648-4
Enhanced gastrointestinal absorption of N3-O-toluyl-fluorouracil by cationic solid lipid nanoparticles
Donghua Liu (2010)
10.1155/2012/750891
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar